Global Infectious Diseases Market Size, Status and Forecast 2024-2031

Report ID: 951074 | Published Date: Oct 2024 | No. of Page: 120 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Antibacterial Drugs
        1.2.3 Antiviral Drugs
        1.2.4 Antifungal Drugs
        1.2.5 Antiparasitic Drugs
    1.3 Market by Application
        1.3.1 Global Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals/Clinical Laboratories
        1.3.3 Reference Laboratories
        1.3.4 Academic/Research Institutes
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Infectious Diseases Market Perspective (2016-2027)
    2.2 Infectious Diseases Growth Trends by Regions
        2.2.1 Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Infectious Diseases Historic Market Share by Regions (2016-2021)
        2.2.3 Infectious Diseases Forecasted Market Size by Regions (2022-2027)
    2.3 Infectious Diseases Industry Dynamic
        2.3.1 Infectious Diseases Market Trends
        2.3.2 Infectious Diseases Market Drivers
        2.3.3 Infectious Diseases Market Challenges
        2.3.4 Infectious Diseases Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Infectious Diseases Players by Revenue
        3.1.1 Global Top Infectious Diseases Players by Revenue (2016-2021)
        3.1.2 Global Infectious Diseases Revenue Market Share by Players (2016-2021)
    3.2 Global Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Infectious Diseases Revenue
    3.4 Global Infectious Diseases Market Concentration Ratio
        3.4.1 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases Revenue in 2020
    3.5 Infectious Diseases Key Players Head office and Area Served
    3.6 Key Players Infectious Diseases Product Solution and Service
    3.7 Date of Enter into Infectious Diseases Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Diseases Breakdown Data by Type
    4.1 Global Infectious Diseases Historic Market Size by Type (2016-2021)
    4.2 Global Infectious Diseases Forecasted Market Size by Type (2022-2027)

5 Infectious Diseases Breakdown Data by Application
    5.1 Global Infectious Diseases Historic Market Size by Application (2016-2021)
    5.2 Global Infectious Diseases Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Infectious Diseases Market Size (2016-2027)
    6.2 North America Infectious Diseases Market Size by Type
        6.2.1 North America Infectious Diseases Market Size by Type (2016-2021)
        6.2.2 North America Infectious Diseases Market Size by Type (2022-2027)
        6.2.3 North America Infectious Diseases Market Size by Type (2016-2027)
    6.3 North America Infectious Diseases Market Size by Application
        6.3.1 North America Infectious Diseases Market Size by Application (2016-2021)
        6.3.2 North America Infectious Diseases Market Size by Application (2022-2027)
        6.3.3 North America Infectious Diseases Market Size by Application (2016-2027)
    6.4 North America Infectious Diseases Market Size by Country
        6.4.1 North America Infectious Diseases Market Size by Country (2016-2021)
        6.4.2 North America Infectious Diseases Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Infectious Diseases Market Size (2016-2027)
    7.2 Europe Infectious Diseases Market Size by Type
        7.2.1 Europe Infectious Diseases Market Size by Type (2016-2021)
        7.2.2 Europe Infectious Diseases Market Size by Type (2022-2027)
        7.2.3 Europe Infectious Diseases Market Size by Type (2016-2027)
    7.3 Europe Infectious Diseases Market Size by Application
        7.3.1 Europe Infectious Diseases Market Size by Application (2016-2021)
        7.3.2 Europe Infectious Diseases Market Size by Application (2022-2027)
        7.3.3 Europe Infectious Diseases Market Size by Application (2016-2027)
    7.4 Europe Infectious Diseases Market Size by Country
        7.4.1 Europe Infectious Diseases Market Size by Country (2016-2021)
        7.4.2 Europe Infectious Diseases Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Infectious Diseases Market Size (2016-2027)
    8.2 Asia-Pacific Infectious Diseases Market Size by Type
        8.2.1 Asia-Pacific Infectious Diseases Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Infectious Diseases Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Infectious Diseases Market Size by Type (2016-2027)
    8.3 Asia-Pacific Infectious Diseases Market Size by Application
        8.3.1 Asia-Pacific Infectious Diseases Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Infectious Diseases Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Infectious Diseases Market Size by Application (2016-2027)
    8.4 Asia-Pacific Infectious Diseases Market Size by Region
        8.4.1 Asia-Pacific Infectious Diseases Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Infectious Diseases Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Infectious Diseases Market Size (2016-2027)
    9.2 Latin America Infectious Diseases Market Size by Type
        9.2.1 Latin America Infectious Diseases Market Size by Type (2016-2021)
        9.2.2 Latin America Infectious Diseases Market Size by Type (2022-2027)
        9.2.3 Latin America Infectious Diseases Market Size by Type (2016-2027)
    9.3 Latin America Infectious Diseases Market Size by Application
        9.3.1 Latin America Infectious Diseases Market Size by Application (2016-2021)
        9.3.2 Latin America Infectious Diseases Market Size by Application (2022-2027)
        9.3.3 Latin America Infectious Diseases Market Size by Application (2016-2027)
    9.4 Latin America Infectious Diseases Market Size by Country
        9.4.1 Latin America Infectious Diseases Market Size by Country (2016-2021)
        9.4.2 Latin America Infectious Diseases Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Infectious Diseases Market Size (2016-2027)
    10.2 Middle East & Africa Infectious Diseases Market Size by Type
        10.2.1 Middle East & Africa Infectious Diseases Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Infectious Diseases Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Infectious Diseases Market Size by Type (2016-2027)
    10.3 Middle East & Africa Infectious Diseases Market Size by Application
        10.3.1 Middle East & Africa Infectious Diseases Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Infectious Diseases Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Infectious Diseases Market Size by Application (2016-2027)
    10.4 Middle East & Africa Infectious Diseases Market Size by Country
        10.4.1 Middle East & Africa Infectious Diseases Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Infectious Diseases Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 F. Hoffmann-La Roche
        11.1.1 F. Hoffmann-La Roche Company Details
        11.1.2 F. Hoffmann-La Roche Business Overview
        11.1.3 F. Hoffmann-La Roche Infectious Diseases Introduction
        11.1.4 F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2016-2021)
        11.1.5 F. Hoffmann-La Roche Recent Development
    11.2 Gilead Sciences
        11.2.1 Gilead Sciences Company Details
        11.2.2 Gilead Sciences Business Overview
        11.2.3 Gilead Sciences Infectious Diseases Introduction
        11.2.4 Gilead Sciences Revenue in Infectious Diseases Business (2016-2021)
        11.2.5 Gilead Sciences Recent Development
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Infectious Diseases Introduction
        11.3.4 GlaxoSmithKline Revenue in Infectious Diseases Business (2016-2021)
        11.3.5 GlaxoSmithKline Recent Development
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Infectious Diseases Introduction
        11.4.4 Johnson & Johnson Revenue in Infectious Diseases Business (2016-2021)
        11.4.5 Johnson & Johnson Recent Development
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Infectious Diseases Introduction
        11.5.4 Merck Revenue in Infectious Diseases Business (2016-2021)
        11.5.5 Merck Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Infectious Diseases Introduction
        11.6.4 Pfizer Revenue in Infectious Diseases Business (2016-2021)
        11.6.5 Pfizer Recent Development
    11.7 AbbVie
        11.7.1 AbbVie Company Details
        11.7.2 AbbVie Business Overview
        11.7.3 AbbVie Infectious Diseases Introduction
        11.7.4 AbbVie Revenue in Infectious Diseases Business (2016-2021)
        11.7.5 AbbVie Recent Development
    11.8 Astellas Pharma
        11.8.1 Astellas Pharma Company Details
        11.8.2 Astellas Pharma Business Overview
        11.8.3 Astellas Pharma Infectious Diseases Introduction
        11.8.4 Astellas Pharma Revenue in Infectious Diseases Business (2016-2021)
        11.8.5 Astellas Pharma Recent Development
    11.9 AstraZeneca
        11.9.1 AstraZeneca Company Details
        11.9.2 AstraZeneca Business Overview
        11.9.3 AstraZeneca Infectious Diseases Introduction
        11.9.4 AstraZeneca Revenue in Infectious Diseases Business (2016-2021)
        11.9.5 AstraZeneca Recent Development
    11.10 Bayer
        11.10.1 Bayer Company Details
        11.10.2 Bayer Business Overview
        11.10.3 Bayer Infectious Diseases Introduction
        11.10.4 Bayer Revenue in Infectious Diseases Business (2016-2021)
        11.10.5 Bayer Recent Development
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Details
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Infectious Diseases Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Infectious Diseases Business (2016-2021)
        11.11.5 Bristol-Myers Squibb Recent Development
    11.12 Chimerix Pharmaceuticals
        11.12.1 Chimerix Pharmaceuticals Company Details
        11.12.2 Chimerix Pharmaceuticals Business Overview
        11.12.3 Chimerix Pharmaceuticals Infectious Diseases Introduction
        11.12.4 Chimerix Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021)
        11.12.5 Chimerix Pharmaceuticals Recent Development
    11.13 Cubist
        11.13.1 Cubist Company Details
        11.13.2 Cubist Business Overview
        11.13.3 Cubist Infectious Diseases Introduction
        11.13.4 Cubist Revenue in Infectious Diseases Business (2016-2021)
        11.13.5 Cubist Recent Development
    11.14 Eli Lilly
        11.14.1 Eli Lilly Company Details
        11.14.2 Eli Lilly Business Overview
        11.14.3 Eli Lilly Infectious Diseases Introduction
        11.14.4 Eli Lilly Revenue in Infectious Diseases Business (2016-2021)
        11.14.5 Eli Lilly Recent Development
    11.15 Isis Pharmaceuticals
        11.15.1 Isis Pharmaceuticals Company Details
        11.15.2 Isis Pharmaceuticals Business Overview
        11.15.3 Isis Pharmaceuticals Infectious Diseases Introduction
        11.15.4 Isis Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021)
        11.15.5 Isis Pharmaceuticals Recent Development
    11.16 Mitsubishi Tanabe Pharma
        11.16.1 Mitsubishi Tanabe Pharma Company Details
        11.16.2 Mitsubishi Tanabe Pharma Business Overview
        11.16.3 Mitsubishi Tanabe Pharma Infectious Diseases Introduction
        11.16.4 Mitsubishi Tanabe Pharma Revenue in Infectious Diseases Business (2016-2021)
        11.16.5 Mitsubishi Tanabe Pharma Recent Development
    11.17 Novartis
        11.17.1 Novartis Company Details
        11.17.2 Novartis Business Overview
        11.17.3 Novartis Infectious Diseases Introduction
        11.17.4 Novartis Revenue in Infectious Diseases Business (2016-2021)
        11.17.5 Novartis Recent Development
    11.18 Sanofi
        11.18.1 Sanofi Company Details
        11.18.2 Sanofi Business Overview
        11.18.3 Sanofi Infectious Diseases Introduction
        11.18.4 Sanofi Revenue in Infectious Diseases Business (2016-2021)
        11.18.5 Sanofi Recent Development
    11.18 Vertex
        .1 Vertex Company Details
        .2 Vertex Business Overview
        .3 Vertex Infectious Diseases Introduction
        .4 Vertex Revenue in Infectious Diseases Business (2016-2021)
        .5 Vertex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Antibacterial Drugs
    Table 3. Key Players of Antiviral Drugs
    Table 4. Key Players of Antifungal Drugs
    Table 5. Key Players of Antiparasitic Drugs
    Table 6. Global Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Infectious Diseases Market Share by Regions (2016-2021)
    Table 10. Global Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Infectious Diseases Market Share by Regions (2022-2027)
    Table 12. Infectious Diseases Market Trends
    Table 13. Infectious Diseases Market Drivers
    Table 14. Infectious Diseases Market Challenges
    Table 15. Infectious Diseases Market Restraints
    Table 16. Global Infectious Diseases Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Infectious Diseases Market Share by Players (2016-2021)
    Table 18. Global Top Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases as of 2020)
    Table 19. Ranking of Global Top Infectious Diseases Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Infectious Diseases Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Infectious Diseases Product Solution and Service
    Table 23. Date of Enter into Infectious Diseases Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Infectious Diseases Revenue Market Share by Type (2016-2021)
    Table 27. Global Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Infectious Diseases Revenue Market Share by Application (2016-2021)
    Table 31. Global Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Infectious Diseases Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Infectious Diseases Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Infectious Diseases Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Infectious Diseases Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Infectious Diseases Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Infectious Diseases Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. F. Hoffmann-La Roche Company Details
    Table 64. F. Hoffmann-La Roche Business Overview
    Table 65. F. Hoffmann-La Roche Infectious Diseases Product
    Table 66. F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 67. F. Hoffmann-La Roche Recent Development
    Table 68. Gilead Sciences Company Details
    Table 69. Gilead Sciences Business Overview
    Table 70. Gilead Sciences Infectious Diseases Product
    Table 71. Gilead Sciences Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 72. Gilead Sciences Recent Development
    Table 73. GlaxoSmithKline Company Details
    Table 74. GlaxoSmithKline Business Overview
    Table 75. GlaxoSmithKline Infectious Diseases Product
    Table 76. GlaxoSmithKline Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 77. GlaxoSmithKline Recent Development
    Table 78. Johnson & Johnson Company Details
    Table 79. Johnson & Johnson Business Overview
    Table 80. Johnson & Johnson Infectious Diseases Product
    Table 81. Johnson & Johnson Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 82. Johnson & Johnson Recent Development
    Table 83. Merck Company Details
    Table 84. Merck Business Overview
    Table 85. Merck Infectious Diseases Product
    Table 86. Merck Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 87. Merck Recent Development
    Table 88. Pfizer Company Details
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Infectious Diseases Product
    Table 91. Pfizer Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 92. Pfizer Recent Development
    Table 93. AbbVie Company Details
    Table 94. AbbVie Business Overview
    Table 95. AbbVie Infectious Diseases Product
    Table 96. AbbVie Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 97. AbbVie Recent Development
    Table 98. Astellas Pharma Company Details
    Table 99. Astellas Pharma Business Overview
    Table 100. Astellas Pharma Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 101. Astellas Pharma Recent Development
    Table 102. AstraZeneca Company Details
    Table 103. AstraZeneca Business Overview
    Table 104. AstraZeneca Infectious Diseases Product
    Table 105. AstraZeneca Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 106. AstraZeneca Recent Development
    Table 107. Bayer Company Details
    Table 108. Bayer Business Overview
    Table 109. Bayer Infectious Diseases Product
    Table 110. Bayer Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 111. Bayer Recent Development
    Table 112. Bristol-Myers Squibb Company Details
    Table 113. Bristol-Myers Squibb Business Overview
    Table 114. Bristol-Myers Squibb Infectious Diseases Product
    Table 115. Bristol-Myers Squibb Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 116. Bristol-Myers Squibb Recent Development
    Table 117. Chimerix Pharmaceuticals Company Details
    Table 118. Chimerix Pharmaceuticals Business Overview
    Table 119. Chimerix Pharmaceuticals Infectious Diseases Product
    Table 120. Chimerix Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 121. Chimerix Pharmaceuticals Recent Development
    Table 122. Cubist Company Details
    Table 123. Cubist Business Overview
    Table 124. Cubist Infectious Diseases Product
    Table 125. Cubist Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 126. Cubist Recent Development
    Table 127. Eli Lilly Company Details
    Table 128. Eli Lilly Business Overview
    Table 129. Eli Lilly Infectious Diseases Product
    Table 130. Eli Lilly Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 131. Eli Lilly Recent Development
    Table 132. Isis Pharmaceuticals Company Details
    Table 133. Isis Pharmaceuticals Business Overview
    Table 134. Isis Pharmaceuticals Infectious Diseases Product
    Table 135. Isis Pharmaceuticals Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 136. Isis Pharmaceuticals Recent Development
    Table 137. Mitsubishi Tanabe Pharma Company Details
    Table 138. Mitsubishi Tanabe Pharma Business Overview
    Table 139. Mitsubishi Tanabe Pharma Infectious Diseases Product
    Table 140. Mitsubishi Tanabe Pharma Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 141. Mitsubishi Tanabe Pharma Recent Development
    Table 142. Novartis Company Details
    Table 143. Novartis Business Overview
    Table 144. Novartis Infectious Diseases Product
    Table 145. Novartis Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 146. Novartis Recent Development
    Table 147. Sanofi Company Details
    Table 148. Sanofi Business Overview
    Table 149. Sanofi Infectious Diseases Product
    Table 150. Sanofi Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 151. Sanofi Recent Development
    Table 152. Vertex Company Details
    Table 153. Vertex Business Overview
    Table 154. Vertex Infectious Diseases Product
    Table 155. Vertex Revenue in Infectious Diseases Business (2016-2021) & (US$ Million)
    Table 156. Vertex Recent Development
    Table 157. Research Programs/Design for This Report
    Table 158. Key Data Information from Secondary Sources
    Table 159. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Infectious Diseases Market Share by Type: 2020 VS 2027
    Figure 2. Antibacterial Drugs Features
    Figure 3. Antiviral Drugs Features
    Figure 4. Antifungal Drugs Features
    Figure 5. Antiparasitic Drugs Features
    Figure 6. Global Infectious Diseases Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals/Clinical Laboratories Case Studies
    Figure 8. Reference Laboratories Case Studies
    Figure 9. Academic/Research Institutes Case Studies
    Figure 10. Other Case Studies
    Figure 11. Infectious Diseases Report Years Considered
    Figure 12. Global Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Infectious Diseases Market Share by Regions: 2020 VS 2027
    Figure 15. Global Infectious Diseases Market Share by Regions (2022-2027)
    Figure 16. Global Infectious Diseases Market Share by Players in 2020
    Figure 17. Global Top Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Diseases as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Infectious Diseases Revenue in 2020
    Figure 19. Global Infectious Diseases Revenue Market Share by Type (2016-2021)
    Figure 20. Global Infectious Diseases Revenue Market Share by Type (2022-2027)
    Figure 21. North America Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Infectious Diseases Market Share by Type (2016-2027)
    Figure 23. North America Infectious Diseases Market Share by Application (2016-2027)
    Figure 24. North America Infectious Diseases Market Share by Country (2016-2027)
    Figure 25. United States Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Infectious Diseases Market Share by Type (2016-2027)
    Figure 29. Europe Infectious Diseases Market Share by Application (2016-2027)
    Figure 30. Europe Infectious Diseases Market Share by Country (2016-2027)
    Figure 31. Germany Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Infectious Diseases Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Infectious Diseases Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Infectious Diseases Market Share by Region (2016-2027)
    Figure 41. China Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Infectious Diseases Market Share by Type (2016-2027)
    Figure 49. Latin America Infectious Diseases Market Share by Application (2016-2027)
    Figure 50. Latin America Infectious Diseases Market Share by Country (2016-2027)
    Figure 51. Mexico Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Infectious Diseases Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Infectious Diseases Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Infectious Diseases Market Share by Country (2016-2027)
    Figure 57. Turkey Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 61. Gilead Sciences Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 62. GlaxoSmithKline Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 64. Merck Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 65. Pfizer Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 66. AbbVie Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 67. Astellas Pharma Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 68. AstraZeneca Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 69. Bayer Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 71. Chimerix Pharmaceuticals Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 72. Cubist Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 73. Eli Lilly Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 74. Isis Pharmaceuticals Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 75. Mitsubishi Tanabe Pharma Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 76. Novartis Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 77. Sanofi Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 78. Vertex Revenue Growth Rate in Infectious Diseases Business (2016-2021)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Bristol-Myers Squibb
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Sanofi
Vertex
Frequently Asked Questions
Infectious Diseases report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Infectious Diseases report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Infectious Diseases report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Infertility

In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. The ... Read More

Infertility Services

In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. The ... Read More

In-flight Broadband

The in-flight broadband market encompasses Services that are employed to provide internet connect ... Read More